1. Home
  2. OLP vs VOGX Comparison

OLP vs VOGX Comparison

Compare OLP & VOGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Liberty Properties Inc.

OLP

One Liberty Properties Inc.

N/A

Current Price

$20.99

Market Cap

471.5M

Sector

Real Estate

ML Signal

N/A

Logo Vogenx Inc Common Stock

VOGX

Vogenx Inc Common Stock

SELL

Current Price

$14.49

Market Cap

482.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OLP
VOGX
Founded
1982
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
471.5M
482.8M
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
OLP
VOGX
Price
$20.99
$14.49
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $25.83
N/A
AVG Volume (30 Days)
★ 80.9K
74.5K
Earning Date
11-03-2026
11-06-2026
Dividend Yield
★ 8.55%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.04
N/A
Revenue
★ $82,740,000.00
N/A
Revenue This Year
$10.43
N/A
Revenue Next Year
$2.86
N/A
P/E Ratio
$20.20
★ N/A
Revenue Growth
★ 1.02
N/A
52 Week Low
$19.86
$12.61
52 Week High
$25.88
$38.41

Technical Indicators

Market Signals
Indicator
OLP
VOGX
Relative Strength Index (RSI) 34.68 37.20
Support Level $20.62 $14.41
Resistance Level $23.60 $22.10
Average True Range (ATR) 0.58 2.32
MACD -0.06 -0.31
Stochastic Oscillator 8.68 21.18

Price Performance

Historical Comparison
OLP
VOGX

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.

About VOGX Vogenx Inc Common Stock

Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.

Share on Social Networks: